Close Banner
Section Free  - Quick Takes

04. Cardiac Abnormalities Identified With Echocardiography in Anorexia Nervosa: Systematic Review and Meta-Analysis

Published on December 1, 2020 Expired on April 1, 2023

James Phelps, M.D.

Research Editor - Psychopharmacology Institute

Key Points

  • Four different changes in cardiac function are associated with anorexia nervosa. All of them generally resolve if weight restoration can be achieved.

Free Downloads for Offline Access

  • Free Download Audio File (MP3)

Text version

People with anorexia nervosa have abnormalities in multiple body systems, from persistent hypoglycemia to muscle wasting. However, 80% of patients with severe anorexia nervosa have cardiac abnormalities. There is good and bad news in this study of echocardiographic changes in patients with severe anorexia nervosa.

Anorexia is such a challenging illness for patients, families, and clinicians. So, let’s start with the good news. All of the echocardiographic abnormalities that we will examine here appear to reverse with weight restoration. This article from Jodie Smythe and colleagues at Oxford is a review of previous echocardiographic studies in which they pooled together findings on 4 variables: Left ventricular mass and size, left ventricular systolic and diastolic function, valvular disorders and pericardial effusions, and the findings on what happens to these variables after weight restoration. Let’s look at each of these changes.

First, a decrease in left ventricular mass: The authors suggest this could be a function of decreased preload and afterload and direct atrophy akin to what is happening in skeletal muscle. Next, there is a reduction in cardiac output, reflecting changes in both systolic and diastolic function. Also, mitral valve prolapse is common—the prevalence in these studies ranges from 53% to 83%. For comparison, in 1 case-control study with thin controls, the mitral valve prolapse rate was 13%. Finally, pericardial effusions were seen in 25% of patients. The proposed mechanisms include myocardial wasting and the loss of pericardial fat, which could cause pericardial layer separation. The authors noted 2 case reports in which patients required pericardiocentesis.

Now, back to the good news that the authors emphasized just as much as their concerning findings. These changes, including the cardiac structural changes, tend to resolve with weight restoration, although it is not easily achieved. As a caution, the authors also note that refeeding can lead to new cardiac problems with an abrupt increase in metabolic processes, which can increase preload and induce electrolyte abnormalities.

They noted 4 cardiomyopathy cases associated with refractory hypoglycemia, 1 of which may have been exacerbated by refeeding. So, in that context, let me offer you a brief aside to understand better cardiac pathophysiology, even though it is not a common finding in anorexia. I recalled this rare cardiomyopathy, the Takotsubo variant, sometimes called broken heart syndrome, usually seen in postmenopausal women. The name comes from a round-bottom, narrow-neck Japanese pot whose shape resembles the dysfunctional left ventricle seen in this stress-related cardiac condition. It is like having an MI complete with ST-segment elevation and increased cardiac enzymes without any vessel narrowing. Fortunately, the syndrome is usually self-limiting with full recovery of ventricular function.

Thus, a case report in anorexia noted that reduced estrogen levels in postmenopausal women might alter the endothelial function and vasomotor reactivity, creating this greater vulnerability to a sympathetic nervous system-mediated myocardial stunning. So, perhaps the reduced estrogen levels in a young woman with severe anorexia might create the same risk, especially in the sympathetic drive created by severe hypoglycemia. Perhaps an abrupt refeeding could increase insulin and acutely lower glucose further.

In summary, this article reminds us that anorexia nervosa is associated with significant cardiac abnormalities, which, fortunately, are likely to normalize when weight restoration is achieved.

Abstract

Cardiac abnormalities identified with echocardiography in anorexia nervosa: systematic review and meta-analysis

Jodie Smythe, Claire Colebourn, Lara Prisco, Tatjana Petrinic, Paul Leeson

Background: Anorexia nervosa affects most organ systems, with 80% suffering from cardiovascular complications.

Aims: To define echocardiographic abnormalities in anorexia nervosa through systematic review and meta-analysis.

Method: Two reviewers independently assessed eligibility of publications from Medline, EMBASE and Cochrane Database of Systematic Reviews registries. Studies were included if anorexia nervosa was the primary eating disorder and the main clinical association in described cardiac abnormalities. Data was extracted in duplicate and quality-assessed with a modified Newcastle-Ottawa scale. For continuous outcomes we calculated mean and standardised mean difference (SMD), and corresponding 95% confidence interval. For dichotomous outcomes we calculated proportion and corresponding 95% confidence interval. For qualitative data we summarised the studies.

Results: We identified 23 eligible studies totalling 960 patients, with a mean age of 17 years and mean body mass index of 15.2 kg/m2. Fourteen studies (469 participants) reported data suitable for meta-analysis. Cardiac abnormalities seen in anorexia nervosa compared with healthy controls were reduced left ventricular mass (SMD 1.82, 95% CI 1.32-2.31, P < 0.001), reduced cardiac output (SMD 1.92, 95% CI 1.38-2.45, P < 0.001), increased E/A ratio (SMD -1.10, 95% CI -1.67 to -0.54, P < 0.001), and increased incidence of pericardial effusions (25% of patients, P < 0.01, 95% CI 17-34%, I2 = 80%). Trends toward improvement were seen with weight restoration.

Conclusions: Patients with anorexia nervosa have structural and functional cardiac changes, identifiable with echocardiography. Further work should determine whether echocardiography can help stratify severity and guide safe patient location, management and effectiveness of nutritional rehabilitation.

Free Files
Success!
Check your inbox, we sent you all the materials there.

Reference

Smythe, J., Colebourn, C., Prisco, L., Petrinic, T., & Leeson, P. (2020). Cardiac abnormalities identified with echocardiography in anorexia nervosa: Systematic review and meta-analysis. The British Journal of Psychiatry, 1-10

Table of Contents

Learning Objectives:

After completing this activity, the learner will be able to:

  1. Rank-order antipsychotics by their metabolic effects and evaluate their impact on cardiovascular risk in people with schizophrenia. 
  2. Determine the value of distinguishing behavioral and cognitive impairment in patients at risk of progression to dementia.
  3. Compare suicide attempt rates in patients with a diagnosis of ADHD, on or off stimulant medications.
  4. Examine the cardiac abnormalities associated with anorexia nervosa and their degree of resolution with weight restoration.
  5. Consider the many ways in which COVID-19 worsens substance use problems. Clinicians may be aware of many of these, but it is still useful to see all in one place the full list from experienced authors.

Original Release Date: 12/01/2020

Review and Re-release Date: 03/01/2023

Expiration Date: 04/01/2023

Relevant Financial Disclosures:

The following planners, faculty, and reviewers have the following relevant financial relationships with commercial interests to disclose:

Dr. Phelps has disclosed the following relationships:

  • McGraw-Hill: book on bipolar disorder
  • W.W. Norton & Co.: books on bipolar disorder

All of the relevant financial relationships listed for these individuals have been mitigated.

Contact Information: For questions regarding the content or access to this activity, contact us at support@psychopharmacologyinstitute.com

Instructions for Participation and Credit:

Participants must complete the activity online during the valid credit period that is noted above.

Follow these steps to earn CME credit:

  1. View the required educational content provided on this course page.
  2. Complete the Post Activity Evaluation for providing the necessary feedback for continuing accreditation purposes and for the development of future activities. NOTE: Completing the Post Activity Evaluation after the quiz is required to receive the earned credit.
  3. Download your certificate.

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Medical Academy LLC and the Psychopharmacology Institute. Medical Academy is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement

Medical Academy designates this enduring activity for a maximum of 0.50 AMA PRA Category 1 credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Free Files
Success!
Check your inbox, we sent you all the materials there.
Continue in the website
Instant access modal

Become a Silver, Gold, Silver extended or Gold extended Member.

2025–26 Psychopharmacology CME Program

Unlock up to 155 CME Credits, including 40 SA CME Credits.